Cor Vasa 2008, 50(1):K005-22

Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2007

1 Centrum pro hypertenzi, III. interní klinika, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha
2 Pracoviště preventivní kardiologie, Institut klinické a experimentální medicíny, Praha
3 Interní kardiologická klinika, Fakultní nemocnice Brno, Brno
4 II. interní klinika, Fakultní nemocnice Plzeň, Plzeň
5 Ústav klinické farmakologie, Fakultní nemocnice Ostrava, Ostrava
6 II. interní klinika kardiologie a angiologie, Všeobecná fakultní nemocnice a 1. lékařská fakulta Univerzity Karlovy, Praha
7 Interní klinika 1. lékařské fakulty a Ústřední vojenská nemocnice, Praha
8 II. interní klinika, Fakultní nemocnice u sv. Anny, Brno
9 I. interní kardioangiologická klinika, Fakultní nemocnice u sv. Anny, Brno
10 Klinika kardiologie, Institut klinické a experimentální medicíny, Praha

Published: January 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2007. Cor Vasa. 2008;50(1):K005.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. Guidelines Committee. J Hypertens 2003;21:1011-3.
    2. Cífková R, Horký K, Widimský J sr, a spol. Doporučení diagnostických a léčebných postupů u arteriální hypertenze - verze 2004. Doporučení České společnosti pro hypertenzi. Vnitř Lék 2004;50:709-22. Go to PubMed...
    3. Julius S, Kjeldsen SE, Weber M, et al. VALUE trial group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004;363:2022-31. Go to original source... Go to PubMed...
    4. Dahlof B, Sever PS, Poulter NR, et al. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendoflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005;366:895-906. Go to original source... Go to PubMed...
    5. Patel A, ADVANCE Collaborative Group: MacMahon S, Chalmers J, Neal B, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370(9590):804-5. Go to original source... Go to PubMed...
    6. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and of the European Society of Cardiology. Guidelines Committee. J Hypertens 2007;25:1105-87.
    7. 2007 ESH-ESC Practice Guidelines for the management of Arterial hypertension. ESH-ESC Task Force on the management of Arterial Hypertension. J Hypertens 2007;25:1751-62.
    8. Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical practise. Guidelines Committee. Eur Heart J 2007;28:2375-414.
    9. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355:865-72. Go to original source... Go to PubMed...
    10. Bulpitt CJ, Beckett NS, Cooke J, et al. Hypertension in the Very Elderly Trial Working Group. Results of the pilot study for the Hypertension in the Very Elderly Trial. J Hypertens 2003;21:2409-17. Go to original source... Go to PubMed...
    11. Widimský J a kolektiv. Arteriální hypertenze. 3. přepracované vydání. Praha: Triton, 2008:1-450.
    12. Mancia G, Brown M, Castaigne A. Outcomes with nifedipine GITS or Co-amilozide in hypertensive diabetics and nondiabetics in Intervention as a Goal in Hypertension (INSIGHT). Hypertension 2003;41:431-6. Go to original source... Go to PubMed...
    13. Mancia G, Grassi G, Zanchetti A. New-onset diabetes and antihypertensive drugs. J Hypertens 2006;24:3-10. Go to original source... Go to PubMed...
    14. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97. Go to original source... Go to PubMed...
    15. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 1998;82:2N-9N. Go to original source... Go to PubMed...
    16. Healey JS, Baranchuk A, Crystal E, et al. Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis. J Am Coll Cardiol 2005;45:1832-1839. Go to original source...

    Return to the content


    Cor et Vasa

    You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

    I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.


    No
    Yes